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Girls and women of reproductive age (WRA) bear a large burden of disease from soil-trans-
mitted helminth (STH) infections worldwide. This burden is primarily attributable to the ane-
mia caused by hookworm and Trichuris trichiura infections [1,2]. Together with preschool
children (pre-SAC) and school-age children (SAC), WRA are one of the three risk groups
most vulnerable to STH morbidity [3,4,5,6], yet the benefits and opportunities for addressing
STH among this group have, until recently, been under-appreciated.
Mupfasoni and colleagues estimate that over 688,000,000 WRA living in STH-endemic
countries were in need of deworming treatment in 2015 [5], and Montresor and colleagues
have further estimated that more than 600,000 disability-adjusted life years (DALYs) are lost
by WRA due to STH, annually [7]. Although coverage rates of deworming in the two child risk
groups have been steadily increasing (from less than 10% in 2003 to more than 60% in 2016
[8]) through school or child health campaign platforms, coverage in WRA has not improved.
Data on treatment coverage for WRA are not routinely collected by national programs, but it
is likely that, as countries successfully transition out of lymphatic filariasis treatment programs
(in which albendazole is included in the treatment regimen), coverage rates of deworming in
WRA may decline. Moreover, although 2002 World Health Organization (WHO) guidance
[9] recommended pregnant women should be treated, uptake of treatment during antenatal
care has been low, due (in part) to a perceived fear of side effects, especially teratogenicity,
among women and health personnel. Operational research is currently underway to identify
an efficient approach to ruling out first-trimester pregnancy to respond to these concerns [10].
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In order to expand treatment among WRA, new community-based strategies are required,
with strategies tailored to reaching each of the different subgroups of WRA (i.e., adolescent
girls, pregnant women, lactating women, and nonpregnant nonlactating women) [11,12]. For
example, deworming can be added to iron supplementation programs targeting pregnant
women, and it can be offered to lactating women at well-baby clinics.
Several government-supported platforms already exist in many countries to reach adoles-
cent girls (e.g., schools), pregnant women (e.g., antenatal care clinics), and lactating women
(e.g., postpartum and well-baby clinics). In addition, women can be reached by piggybacking
onto other highly successful campaigns like Child Health Days and new efforts to increase uni-
versal health care coverage [13,14]. There are also many untapped opportunities to reach the
majority of at-risk WRA and innovative approaches (e.g., use of social technologies, among
others) will be needed to ensure that coverage is optimal. With these opportunities also come
challenges that will need to be overcome. First, there is no drug donation program for WRA,
with current donation programs for SAC only. Second, special considerations need to be made
Fig 1. The Bellagio Declaration.
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for women who are pregnant, as deworming is contraindicated in the first trimester. Third,
appropriate messaging is required to educate women and health personnel of the safety and
benefits of deworming in order to help allay fears of perceived side effects. Finally, there are a
number of outstanding basic and operational research issues that merit further investigation,
including monitoring and evaluating the impact of deworming programs targeting WRA on
maternal and infant outcomes and evaluating the cost-effectiveness of different platforms for
reaching WRA, among others.
Clear policy and guidance are also essential to support country efforts to expand routine
deworming of WRA, and two recent WHO publications have provided the necessary policy
framework. The first is the new evidence-informed guideline on preventive chemotherapy
which documents deworming recommendations for all three high-risk groups (SAC, pre-SAC,
and WRA [including adolescent girls]) [15]. It reaffirms deworming in all at-risk WRA sub-
groups, including pregnant women, after the first trimester. The second, a report of an interna-
tional expert advisory group meeting, is the 2018 update to the 1994 Report of the WHO
Informal Consultation on Hookworm Infection and Anemia in Girls and Women [16, 17].
This report, focusing specifically on WRA, summarizes the group’s deliberations, outlining a
set of recommendations and research priorities, and informing the meeting’s unanimously
adopted Bellagio Declaration (Fig 1).
This declaration represents a seminal landmark for the promotion of the rights and liveli-
hoods of WRA living in STH-endemic areas of the world. All stakeholders in women’s health
should take immediate action in their respective domains to ensure that WRA are now
included in their STH policies, programs, and clinical and operational research priorities.
Such collective action will ensure that every girl and woman of reproductive age at-risk of STH
can benefit from effective treatment.
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